Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study.
about
Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns.Regulatory approval pathways for anticancer drugs in Japan, the EU and the US.Investigating cell therapy for inflammatory bowel disease.Remestemcel-L for the treatment of graft versus host disease.Mesenchymal stromal cells and autoimmunity.TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling.Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders.Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy.Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.The Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles on Hematopoietic Stem Cells Fate.Accelerating regenerative medicine: the Japanese experiment in ethics and regulation.Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation.Interferon-γ mediates the immunosuppression of bone marrow mesenchymal stem cells on T-lymphocytes in vitro.Advance in Targeted Immunotherapy for Graft-Versus-Host Disease.Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol.
P2860
Q33755190-B741EF1C-AB8A-4E9D-BF2C-380332185B41Q38694213-8B79CD1E-C385-4C67-AD65-F14BC68432B8Q38809624-C110BFD2-631B-405E-98F1-8DF0F1B45468Q38817393-0AC7ACA0-779B-4936-8029-28B7FA986684Q38892351-8F546907-666A-4FDF-81E3-4F397765EB8DQ39198564-3409CF2D-4A8F-47F1-A9D7-431E87A2EDD8Q39443690-7F373466-F095-4202-8A65-F55D36B92272Q47138648-17AB904C-08A3-4497-9158-0A5461151D49Q47155255-C45DF823-3500-481F-8C24-98A2C9FBC94BQ48120041-9673D923-8FEB-4F77-BAB7-6438A117BDBFQ49332525-2EA55B41-E544-4AC5-A4F5-BF251681B5D1Q49613181-85EEEF9C-4898-4FCB-AA46-D140DBB88E65Q50847625-83EF82ED-3F4C-4B60-AB80-49870D9DCABAQ53245753-46E0B96B-0F69-4E1E-BB92-9D5A565C92CBQ54937398-563ECB88-58DA-4159-81E5-D9421D3A0F42Q55331096-FEE8222E-01D4-4EF4-8001-F292CA8F141A
P2860
Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bone marrow-derived mesenchyma ...... disease: a phase II/III study.
@en
type
label
Bone marrow-derived mesenchyma ...... disease: a phase II/III study.
@en
prefLabel
Bone marrow-derived mesenchyma ...... disease: a phase II/III study.
@en
P2093
P2860
P1476
Bone marrow-derived mesenchyma ...... disease: a phase II/III study.
@en
P2093
Junji Tanaka
Kazuo Muroi
Kazuteru Ohashi
Keiya Ozawa
Koichi Miyamura
Makoto Murata
Mariko Yamaoka
Masahiro Imamura
Masaki Mori
Masaya Okada
P2860
P2888
P304
P356
10.1007/S12185-015-1915-9
P577
2015-11-25T00:00:00Z